Life Sciences Litigation & Enforcement Team
D. Mass Holds Plaintiffs Failed to Plead Securities Law Violation Regarding Company’s Statements Concerning Manufacturing of Eye Drug
Life Sciences Securities Litigation ·
S.D.N.Y. Dismisses Investor Suit Concerning Pancreatic Cancer Drug Study
Life Sciences Securities Litigation ·
S.D.N.Y. Partially Dismisses Shareholder Class Action Claims Based on Pharmaceutical Company’s Nonactionable Statements of Opinion
Life Sciences Securities Litigation ·
Unanimous Sixth Circuit Reverses Dismissal, Finding Plaintiffs Plausibly Alleged Defendants Knew Statements Summarizing FDA Meeting Were False
Life Sciences Securities Litigation ·